By continuing to use this site you consent to the use of cookies on your device. Find out more about our cookie policy and the types of cookies we use by clicking here

Stocks In Limbo As Commodities Weaken -- Canadian Commentary

WASHINGTON (Alliance News) - Canadian stocks may struggle to break out of a recent funk ...

Alliance News 7 December, 2017 | 2:03PM
Email Form

WASHINGTON (Alliance News) - Canadian stocks may struggle to break out of a recent funk Thursday amid a lack of positive catalysts ahead of next week's likely US interest rate hike.

Crude oil prices have tumbled near USD56 and gold is in retreat at 4-month lows.

The TSX Composite Index has fallen below 16,000 from record highs in November.

Yesterday, the Bank of Canada held steady on interest rates for a second meeting in a row.

In corporate news, Lululemon (LLL.TO) reported same-store sales that exceeded estimates. Shares were upgraded by numerous ratings agencies. The stock is expected to open higher by 10%.

CanniMed Therapeutics Inc. (CMED.TO) says it has entered into a definitive agreement with PharmaChoice to supply cannabis products across Canada. CMED is the subject of a hostile takeover offer by Aurora Cannabis Inc. (ACB.TO).

Kinder Morgan (KML.TO) has sold shares to help fund the Trans Mountain pipeline plan.

On the economic front, Canadian municipalities issued USD8.2 billion worth of building permits in October, up 3.5% from the previous month, Stats Canada said.

Copyright RTT News/dpa-AFX

Email Form
About Author Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.